Trabectedin Shows Efficacy in Patients With Advanced Myxoid Liposarcomas

The novel marine-derived alkaloid agent trabectedin demonstrated antitumor activity in more than half of patients with advanced myxoid liposarcomas, who have previously undergone other types of treatment.Roxanne Nelson

Continue to Trabectedin Shows Efficacy in Patients With Advanced Myxoid Liposarcomas on Medscape Medical News Headlines.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz